Get started
Author

Maria Antonietta Gambacorta

Observed names: M A Gambacorta, Maria Antonietta Gambacorta, Maria Antonietta Gambacorta
ORCID: 0000-0001-5455-8737
Observed ORCID: 0000-0001-5455-8737
OpenAlex ID: A5010722046
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial
2024 · Gabriella Macchia, Maura Campitelli, et al. · International Journal of Radiation Oncology*Biology*Physics · 20
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I
2024 · Luca Nicosia, Marco Lorenzo Bonù, et al. · Radiotherapy and Oncology · 15
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups
2023 · Gabriella Macchia, Donato Pezzulla, et al. · International Journal of Radiation Oncology*Biology*Physics · 15
PDF
AI-driven online adaptive radiotherapy in prostate cancer treatment: considerations on activity time and dosimetric benefits
2025 · Francesco Preziosi, Althea Boschetti, et al. · Radiation Oncology · 12
PDF
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
2025 · Federico Monaca, Igor Gomez-Randulfe, et al. · European Journal of Cancer · 11
PDF
Optimal Sequence for Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: An Evidence‐Based Review
2024 · Reza Ghalehtaki, Forouzan Nourbakhsh, et al. · Cancer Medicine · 11
PDF
Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: A single center experience
2024 · Brunella Barbaro, Maria Rachele PIa Carafa, et al. · Radiotherapy and Oncology · 10
Treatment of Oligometastatic Parenchymal Lesions in Ovarian Cancer With Stereotactic Ablative Radiation Therapy: A Multicenter Prospective Phase 2 Trial (MITO RT3/RAD)
2025 · Gabriella Macchia, Donato Pezzulla, et al. · International Journal of Radiation Oncology*Biology*Physics · 8
Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art
2024 · Luca Tagliaferri, Bruno Fionda, et al. · Strahlentherapie und Onkologie · 5
PDF
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups
2025 · Gabriella Macchia, Donato Pezzulla, et al. · Anti-Cancer Drugs · 4
Artificial intelligence in interventional radiotherapy (brachytherapy): Enhancing patient-centered care and addressing patients’ needs
2024 · Bruno Fionda, Elisa Placidi, et al. · Clinical and Translational Radiation Oncology · 3
PDF
Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?
2025 · Rosa Autorino, Gabriella Macchia, et al. · Strahlentherapie und Onkologie · 2
High-Tailored Anal canal Radiotherapy (HIT-ART): Long term results of MR image-guided interventional radiotherapy (brachytherapy) boost
2025 · Luca Tagliaferri, Stefania Manfrida, et al. · Brachytherapy · 2
PDF
Stereotactic Ablative Radiotherapy for Oligometastatic Ovarian Cancer Parenchymal Disease: the Mito-rt3/rad Phase Ii Trial
2025 · Gabriella Macchia, Donato Pezzulla, et al. · International Journal of Gynecological Cancer · 2
PDF
Quality control strategies for head and neck brachytherapy (interventional radiotherapy)
2025 · Bruno Fionda, Elisa Placidi, et al. · Journal of Contemporary Brachytherapy · 2
PDF
Ladies project: large database in endometrial cancers for a personalized treatment
2024 · Rosa Autorino, Raffaella Michela Rinaldi, et al. · La radiologia medica · 2
PDF
A systematic review on the role of interventional radiotherapy for treatment of anal squamous cell cancer: multimodal and multidisciplinary therapeutic approach
2024 · Maria Concetta Campisi, Valentina Lancellotta, et al. · La radiologia medica · 2
Timing matters: how mechanism-guided sequencing shapes the efficacy of radiotherapy-immunotherapy combinations
2026 · Carlo Guglielmo Cattaneo, Enrico Pozzo, et al. · Strahlentherapie und Onkologie · 1
MRI-guided stereotactic radiotherapy for oligometastatic peritoneal carcinomatosis: toward integrative oncologic approaches
2025 · Angela Romano, Giuditta Chiloiro, et al. · Clinical & Experimental Metastasis · 1
Comment on: “Risk of distant metastasis after local excision for near-complete response versus salvage surgery for local regrowth in rectal cancer: Results from an international registry”
2025 · Quoc Riccardo Bao, Quoc Riccardo Bao, et al. · European Journal of Surgical Oncology · 1
4243 Re-irradiation After Re-surgery in Recurrent Glioblastoma: A Viable Strategy? Evaluating Its Role in Improving Survival Outcomes
2025 · Antonella Martino, Lucia Di Maio, et al. · Radiotherapy and Oncology · 1
Brief clinical exposure boosts radiation oncology awareness among Italian medical students
2025 · Raffaella Michela Rinaldi, Mariangela Massaccesi, et al. · Journal of Radiotherapy in Practice · 1
PDF
PT006/#314 Stereotactic ablative radiotherapy for oligometastatic ovarian cancer lymph node disease: the MITO-RT3/rad phase II trial
2024 · Gabriella Macchia, Maura Campitelli, et al. · International Journal of Gynecological Cancer · 1
3057: Clinical impact of ESMO guidelines adherence in rectal cancer: a process mining of Real World
2024 · Data Silvia Di Franco, Giuditta Chiloiro, et al. · Radiotherapy and Oncology · 1
Comparative efficacy of stereotactic body radiotherapy versus radiofrequency catheter ablation in refractory ventricular tachyarrhythmia: results from the vt-art consortium
2026 · O Anzalone, F Percio, et al. · EP Europace
Works count: 76
Citation count: 133
H-index: 8
I10-index: 7
Year
Topic
Type